Laurence W. Lytton 13D and 13G filings for NeuroOne Medical Technologies Corporation:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-11-26 08:42 am Purchase | 2024-09-30 | 13G | NeuroOne Medical Technologies Corporation NMTC | Laurence W. Lytton | 2,059,922 6.600% | 755,820 (+57.96%) | Filing |
| 2024-01-11 1:04 pm Purchase | 2023-12-28 | 13G | NeuroOne Medical Technologies Corporation NMTC | Laurence W. Lytton | 1,304,102 5.200% | 1,304,102 (New Position) | Filing |